475 related articles for article (PubMed ID: 26264371)
1. Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement.
Lindman BR; Zajarias A; Maniar HS; Miller DC; Suri RM; Arnold SV; Webb J; Svensson LG; Kodali S; Xu K; Ayele GM; Lin F; Wong SC; Babaliaros V; Thourani VH; Douglas PS; Lim S; Leon MB; Mack MJ
Heart; 2015 Oct; 101(20):1656-64. PubMed ID: 26264371
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
[TBL] [Abstract][Full Text] [Related]
3. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial.
Thourani VH; Forcillo J; Beohar N; Doshi D; Parvataneni R; Ayele GM; Kirtane AJ; Babaliaros V; Kodali S; Devireddy C; Szeto W; Herrmann HC; Makkar R; Ailawadi G; Lim S; Maniar HS; Zajarias A; Suri R; Tuzcu EM; Kapadia S; Svensson L; Condado J; Jensen HA; Mack MJ; Leon MB
Ann Thorac Surg; 2016 Oct; 102(4):1172-80. PubMed ID: 27592092
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
[TBL] [Abstract][Full Text] [Related]
5. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
[TBL] [Abstract][Full Text] [Related]
6. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis.
Bishu K; Suri RM; Nkomo VT; Kane GC; Greason KL; Reeder GS; Mathew V; Holmes DR; Rihal CS; Melduni RM
Am J Cardiol; 2014 Nov; 114(10):1562-7. PubMed ID: 25260946
[TBL] [Abstract][Full Text] [Related]
8. Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement.
Zlotnick DM; Ouellette ML; Malenka DJ; DeSimone JP; Leavitt BJ; Helm RE; Olmstead EM; Costa SP; DiScipio AW; Likosky DS; Schmoker JD; Quinn RD; Sisto D; Klemperer JD; Sardella GL; Baribeau YR; Frumiento C; Brown JR; O'Rourke DJ;
Am J Cardiol; 2013 Nov; 112(10):1635-40. PubMed ID: 23998349
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement.
Barbash IM; Escarcega RO; Minha S; Ben-Dor I; Torguson R; Goldstein SA; Wang Z; Okubagzi P; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2015 May; 115(10):1435-42. PubMed ID: 25776456
[TBL] [Abstract][Full Text] [Related]
10. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.
Alushi B; Beckhoff F; Leistner D; Franz M; Reinthaler M; Stähli BE; Morguet A; Figulla HR; Doenst T; Maisano F; Falk V; Landmesser U; Lauten A
JACC Cardiovasc Imaging; 2019 Apr; 12(4):591-601. PubMed ID: 29680341
[TBL] [Abstract][Full Text] [Related]
13. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial.
Svensson LG; Blackstone EH; Rajeswaran J; Brozzi N; Leon MB; Smith CR; Mack M; Miller DC; Moses JW; Tuzcu EM; Webb JG; Kapadia S; Fontana GP; Makkar RR; Brown DL; Block PC; Guyton RA; Thourani VH; Pichard AD; Bavaria JE; Herrmann HC; Williams MR; Babaliaros V; Généreux P; Akin JJ;
J Am Coll Cardiol; 2014 Jul; 64(2):158-68. PubMed ID: 25011720
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
17. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve.
Pibarot P; Hahn RT; Weissman NJ; Arsenault M; Beaudoin J; Bernier M; Dahou A; Khalique OK; Asch FM; Toubal O; Leipsic J; Blanke P; Zhang F; Parvataneni R; Alu M; Herrmann H; Makkar R; Mack M; Smalling R; Leon M; Thourani VH; Kodali S
JAMA Cardiol; 2017 Nov; 2(11):1208-1216. PubMed ID: 28973091
[TBL] [Abstract][Full Text] [Related]
18. Two-year outcomes after transcatheter or surgical aortic-valve replacement.
Kodali SK; Williams MR; Smith CR; Svensson LG; Webb JG; Makkar RR; Fontana GP; Dewey TM; Thourani VH; Pichard AD; Fischbein M; Szeto WY; Lim S; Greason KL; Teirstein PS; Malaisrie SC; Douglas PS; Hahn RT; Whisenant B; Zajarias A; Wang D; Akin JJ; Anderson WN; Leon MB;
N Engl J Med; 2012 May; 366(18):1686-95. PubMed ID: 22443479
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation.
Toggweiler S; Boone RH; Rodés-Cabau J; Humphries KH; Lee M; Nombela-Franco L; Bagur R; Willson AB; Binder RK; Gurvitch R; Grewal J; Moss R; Munt B; Thompson CR; Freeman M; Ye J; Cheung A; Dumont E; Wood DA; Webb JG
J Am Coll Cardiol; 2012 Jun; 59(23):2068-74. PubMed ID: 22483326
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
